Parkinson's Disease
Gordon Research Conference

June 25-30, 2017
Grand Summit Hotel
Newry, ME, USA

20 years of alpha-synuclein in
Parkinson's Disease
September 7-10 2017

Hotel Mare Nostrum
Athens, Greece

BUSINESS OPPORTUNITIES

An integral part of our business strategy is to contribute our proprietary technology with full commitment to strenghten the core competencies of our partners. Our track record proves the success of our integrated concept. Since our platform technology is based on a modular and scalable concept it allows entry points at several project stages from early discovery to clinical phases available for partnering.

 

Please contact licensing(at)origenis.com